|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Biopharmaceuticals | AstraZeneca PLC (NYSE: AZN) | Arrow Therapeutics Ltd. |
| Strengthens AstraZeneca's portfolio of promising anti-infective treatments. Deal Value -- more... | ||
| Biopharmaceuticals | Forest Laboratories, Inc. (NYSE: FRX) | Cerexa, Inc. |
| Forest obtains development and marketing rights worldwide excluding Japan to Ceftaroline, a novel antibiotic in Phase 3 clinical trials, an more... | ||
| Biopharmaceuticals | Hospira, Inc. (NYSE: HSP) | Mayne Pharma Limited (ASX: MYP) |
| Doubles Hospira’s international sales and vastly upgrades its fledgling international distribution network. About 75% of Mayne’s $600m in more... | ||
| Biopharmaceuticals | Ikaria Inc. | INO Therapeutics |
| The Deal, valued at - $670m, will create a leadership position in therapeutic gases and critical care medicine. Financed by New Mountain Capital, more... | ||
| Biopharmaceuticals | Meda AB | 3M's (NYSE:MMM) European pharmaceutical business. |
| Fortifies Meda as a leading European specialty pharmaceutical company. Deal value $860m (10x EBITDA). 3m sold its Asian pharmaceutical operations to more... | ||
| Biopharmaceuticals | Schering-Plough Corporation (SGP) | Organon BioSciences N.V. |
| Builds on Schering-Plough's growing strength in primary care, giving it immediate access to central nervous system (CNS) and women's health more... | ||
| Data Management/ Healthcare IT | Haemonetics Corporation (NYSE:HAE) | Information Data Management, Inc. |
| The acquisition will enable Haemonetics to deliver an information management infrastructure to support blood collection and processing. Deal value -- more... | ||
| Data Management/ Healthcare IT | Huron Consulting Group Inc. (HURN) | Wellspring Partners LTD |
| Huron and Wellspring will provide a wider complement of consulting services to community hospitals, academic medical centers and other healthcare more... | ||
| Data Management/ Healthcare IT | McKesson Corp. | Per-Se Technologies |
| With the acquisition, McKesson estimates that the number of Deal-processing services for physicians and hospitals will more than double, to more... | ||
| Dental | DTI Dental Technologies, Inc. | MicroDental Laboratories, Inc. |
| The combination permits the two companies to avail of many synergies, share technology, and enhance continuing education to their technicians and more... | ||
| Diagnostics | 3M | Acolyte Biomedica Ltd. |
| Builds on 3M's R&D in medical diagnostics and is a natural extension of its core infection prevention business. 3M will be able to provide more... | ||
| Diagnostics | Cepheid (NYSE: CPHD) | Sangtec Molecular Diagnostics AB |
| Gives Cepheid a product line for potential use in managing infections of immunocompromised patients. Deal value -- $27m on revenue of $8m more... | ||
| Diagnostics | Cytyc Corporation | Adeza Biomedical Corporation |
| Complements Cytec's lines and leverages its worldwide sales force that includes a U.S. OBGYN sales force of approximately 200 people, a U.S. more... | ||
| Diagnostics | Cytyc Corporation (CYTC) | Adiana, Inc. |
| Synergizes with Cytyc's existing products directed at OBGYNs. Cytyc estimates the market opportunity for the product in the United States to be more... | ||
| Diagnostics | Illumina, Inc. | Solexa, Inc. |
| Creates the only company with genome-scale technology for genotyping, gene expression and sequencing, the three cornerstones of modern genetic more... | ||
| Diagnostics | Inverness Medical Innovations, Inc. (AMEX: IMA) | First Check Diagnostics LLC |
| First Check's tests can be conducted at home to detect drug abuse of substances such as marijuana, cocaine, methamphetamines, opiates and more... | ||
| Diagnostics | Inverness Medical Innovations, Inc. (AMEX: IMA) | Promesan S.r.l. |
| Marks Inverness' first direct presence in Italy and provides it with an established Italian commercial and distribution network for its more... | ||
| Diagnostics | Inverness Medical Innovations, Inc. (AMEX: IMA) | Instant Technologies, Inc. |
| For $43.7m, Inverness buys 75% of Instant Technologies, the largest single distributor for Inverness' drugs of abuse testing products. There are more... | ||
| Diagnostics | Luminex Corporation (NASDAQ:LMNX) | Tm Bioscience Corporation (TSX: TMC) |
| Furthers Luminex's goal to be a leader in the fast growing molecular diagnostics market. Tm has proprietary technologies that improve the speed, more... | ||
| Diagnostics | MDS Inc. | Molecular Devices Corp. |
| Strengthen MDS' position as one of the top global providers of life sciences solutions, with high content screening, cellular and biochemical more... | ||
| Diagnostics | PerkinElmer, Inc. (NYSE: PKI) | The Thermal Analysis product line of UK-based Triton Technology Ltd. |
| Provides a leading thermal analysis tool that combines ease-of-use and flexibility with powerful performance. Terms not more... | ||
| Diagnostics | Quest Diagnostics Incorporated | HemoCue |
| Puts Quest into the growing near patient testing market and leverage HemoCue's international presence. HemoCue's handheld systems are used in more... | ||
| Diagnostics | Siemens AG | The Bayer Diagnostic Unit of Bayer AG |
| This $5.3b acquisition, the second major purchase by Siemens' healthcare unit in two months, will make Siemens the world's second largest more... | ||
| Distribution | Owens & Minor (NYSE: OMI) | McKesson's Acute-Care Medical and Surgical Supply Distribution Business (NYSE: MCK) |
| Strategic fit for OMI -- acquires an expanded customer base and sales team and key acute-care employees from McKesson. Deal value - $170m. McKesson more... | ||
| Medical Devices | Advanced Medical Optics, Inc. (NYSE: EYE ) | WaveFront Sciences, Inc. |
| Expands AMO's portfolio of laser technologies and strengthens its pipeline of new wavefront-guided diagnostic innovations .Deal value -- $14m more... | ||
| Medical Devices | Allergan, Inc. (NYSE:AGN) | EndoArt SA |
| The acquisition builds upon Allergan’s existing obesity intervention product portfolio. Deal value -- more... | ||
| Medical Devices | Aspen Surgical Products | Ultracell Medical Technologies |
| This is another add-on acquisition for Aspen, a portfolio company of Roundtable Healthcare Partners. Aspen moved the operations into its main more... | ||
| Medical Devices | Boston Scientific Corp. (BSX) | EndoTex Interventional Systems Inc |
| The acquisition follows the FDA approval of BSX's NexStent Carotid Stent System and FilterWire EZ Embolic Protection System used for more... | ||
| Medical Devices | Candela Corporation (CLZR) | Inolase, LTD |
| Leverages Candela's distribution channels in offering a new technology that has been shown to reduce the pain associated with laser and more... | ||
| Medical Devices | CardioNet, Inc. | PDSHeart, Inc. |
| Creates the largest U.S outpatient cardiac monitoring company, with expanded distribution channels, wider breadth of services and greater technical more... | ||
| Medical Devices | China Medical Technologies | The fluorescent in situ hybridization ("FISH") business of Supreme Well Investments Limited and Molecular Diagnostics Technologies Limited |
| FISH is a type of hybridization in which a DNA probe is labeled with fluorescent dye so that it can be seen with a microscope. China Medical intends more... | ||
| Medical Devices | Cooper Companies, Inc. (NYSE:COO) | Wallach Surgical Devices, Inc. |
| Wallach was a principal competitor. Adds manufacturing capabilities and expands CooperSurgical's reach into the general practitioner market (in more... | ||
| Medical Devices | Johnson & Johnson | Conor Medsystems Inc. |
| After losing to Boston Scientific on the Guidant deal, Conor provides immediate muscle to J&J's drug-eluting stent pipeline, but the Conor more... | ||
| Medical Devices | Kyphon Inc. (NASDAQ: KYPH) | St. Francis Medical Technologies, Inc. |
| Broadens Kyphon's focus in minimally invasive spine solutions, adding to its existing balloon kyphoplasty technologies for repairing vertebral more... | ||
| Medical Devices | MIV Therapeutics Inc. (OTCBB: MIVT ; FWB: MIV) | Biosync Scientific |
| The Biosync Scientific acquisition is the latest step in MIVT's strategic plan to become a world leader in the $8 billion plus interventional more... | ||
| Medical Devices | NuVasive, Inc. (Nasdaq: NUVA) | Radius Medical, LLC |
| Provides NuVasive with a platform for the potential development of more powerful biologic products and sales growth via its exclusive sales force. more... | ||
| Medical Devices | Physio-Control, Inc. | Medtronic, Inc. (NYSE:MDT) |
| In this spin-off, Physio-Control, acquired by Medtronic in 1998, will be better able to pursue its core defibrillator business, which is no longer more... | ||
| Medical Devices | Tornier Inc. | Nexa Orthopedics, Inc. |
| Represents a significant expansion of Tornier's product portfolio for surgeons performing procedures on the extremities, and expands its more... | ||
| Medical Devices | Varian Medical Systems, Inc., (NYSE: VAR) | ACCEL Instruments GmbH (Germany) |
| Proton therapy capabilities supplement Varian's radiotherapy systems. Deal value --- $30m on $30m or more... | ||
| Medical Devices | Zimmer Holdings, Inc. (NYSE:ZMH ) | Endius |
| Endius' implants and techniques to treat spine disease complement Zimmer's orthopedic lines. Terms not disclosed, but deal is subject of more... | ||
| Medical Services | Amedisys Inc. | TLC Health Care Services Inc. |
| Amedisys will now have more than 100 home health agencies; it will have over 480 agencies in 35 states, Puerto Rico and the District of Columbia. more... | ||
| Medical Services | CCMP Capital Advisors and GS Capital Partners | Triad Hospitals, Inc. (NYSE: TRI) |
| After reviewing its strategic options, Triad decides to go private in a $6.4b deal. CCMP is leading private equity firm originating from JPMorgan more... | ||
| OTC/Consumer | The Perrigo Company (PRGO;TASE) | Qualis, Inc. |
| Purchased products include store brand OTC product formulations that compare to Rid® and Nix®, adding to Perrigo's conusmer healthcare more... | ||
| OTC/Consumer | Whitestone Corporation | Humanicare International |
| Together, Whitestone and Humanicare will be a leading provider of products for the adult incontinence care markets. Whitestone is a portfolio company more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||